$LIS · LIS Technologies Inc
LIS Technologies Inc. filed Amendment No. 1 to its S-1 for a firm-commitment IPO of 3,100,000 common shares at an assumed $6.00 midpoint (range $5.00–$7.00), with a 30-day over-allotment option for 465,000 additional shares. The company is an early-stage, pre-revenue developer of laser-based uranium enrichment (CRISLA) technology and has accumulated net losses of $65,418,743 since inception (December 31, 2021) through July 31, 2026. Underwriting discount is 6.5% per share plus a 0.5% non-accountable expense allowance and 7% warrant coverage; CEO Jay Jiang Yu and President Christo J. Liebenberg have each indicated interest in buying up to $250,000 of shares.
- Offering is 3,100,000 shares at $5.00–$7.00 per share, assumed $6.00 midpoint.
- Company has generated no revenues and accumulated net losses of $65,418,743 through July 31, 2026.
- Underwriters receive 6.5% discount, 0.5% non-accountable allowance, and warrants for 7% of shares sold.
- CEO and President each indicated interest in buying up to $250,000 of shares in the offering.
- Listing on Nasdaq under symbol "LIS" is a condition; offering will not close without approval.
Price data unavailable.
A pre-revenue nuclear-fuel startup is testing public-market appetite for a speculative, capital-intensive enrichment technology with no commercial license yet.
The offering targets the domestic uranium enrichment supply chain, which has tightened following the 2024 Prohibiting Russian Uranium Imports Act.
Pre-revenue with $65.4M accumulated losses; no NRC commercial license yet; Nasdaq listing not assured; insider share purchases are non-binding indications of interest.